Skip to Content
Merck
CN

1224802

USP

Docusate sodium

United States Pharmacopeia (USP) Reference Standard

Synonym(s):

Docusate sodium salt, AOT, Bis(2-ethylhexyl) sulfosuccinate sodium salt, Sodium bis(2-ethylhexyl) sulfosuccinate, Sulfobutanedioic acid bis(2-ethylhexyl ester) sodium salt, Sulfosuccinic acid bis(2-ethylhexyl) ester sodium salt, Dioctyl sulfosuccinate sodium salt

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
C20H37NaO7S
CAS Number:
577-11-7
Molecular Weight:
444.56
UNSPSC Code:
41116107
NACRES:
NA.24
PubChem Substance ID:
329749663
MDL number:
MFCD00012455
Beilstein/REAXYS Number:
4117588

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Docusate sodium, United States Pharmacopeia (USP) Reference Standard

InChI key

APSBXTVYXVQYAB-UHFFFAOYSA-M

SMILES string

[Na+].CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S([O-])(=O)=O

InChI

1S/C20H38O7S.Na/c1-5-9-11-16(7-3)14-26-19(21)13-18(28(23,24)25)20(22)27-15-17(8-4)12-10-6-2;/h16-18H,5-15H2,1-4H3,(H,23,24,25);/q;+1/p-1

grade

pharmaceutical primary standard

API family

docusate calcium

manufacturer/tradename

USP

application(s)

pharmaceutical (small molecule)

format

neat

Looking for similar products? Visit Product Comparison Guide

Related Categories

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Application

Docusate sodium USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:
  • Docusate Sodium Solution
  • Docusate Sodium Tablets
  • Docusate Sodium Syrup
  • Docusate Sodium Capsules
  • Ferrous Fumarate and Docusate Sodium Extended-Release Tablets
  • Docusate Potassium Capsules
Forms reverse micelles in hydrocarbon solvents; Suitable for the solubilization of the major myelin transmembrane proteolipid

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Other Notes

Sales restrictions may apply.

pictograms

Corrosion
GHS05

signalword

Danger

hcodes

H315,H318

Hazard Classifications

Eye Dam. 1 - Skin Irrit. 2

Storage Class

11 - Combustible Solids

wgk

WGK 2

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Docusate Sodium Tablets
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 1481-1481 (2020)
Docusate Sodium Syrup
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 1481-1481 (2013)
Docusate Sodium Solution
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 1480 (2013)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service